This study investigates the degree of improvement in insulin resistance and features of the metabolic syndrome in non-diabetic overweight or obese subjects after training in a low-intensity, moderate-intensity or non-aerobic exercise program, as well as self-initiated exercise behavior after the assigned exercise program.
The proposed study is a randomized, open study comparing low-intensity and moderate-intensity aerobic exercise versus non-aerobic (stretching) exercise on direct measurements of insulin resistance and variables associated with the metabolic syndrome. This 6-month intervention will be followed by an additional 6-month follow-up period during which subjects will be encouraged to maintain their exercise regimen (along with their prescribed diet) but without scheduled supervision. Behavioral variables associated with adherence will be analyzed along with changes in the above physiological variables.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
93
Treadmill walking at 30% of VO2Reserve, 3-5 times per week at 20-60 minutes per session, progressive.
Treadmill walking at 60% of VO2Reserve, 3-5 times per week at 20-60 minutes per session, progressive.
Floor stretching exercise, 3-5 times per week at 20-60 minutes duration per session, progressive.
Charles Drew University of Medicine and Science
Los Angeles, California, United States
Insulin sensitivity (clamp)
Time frame: 6 months
Aerobic fitness (VO2Max, Anaerobic threshold, endurance time)
Time frame: 6 and 12 months
Body mass index, waist circumference
Time frame: 6 and 12 months
Fat mass, fat-free mass, lean body mass (DEXA)
Time frame: 6 and 12 months
Blood pressure
Time frame: 6 and 12 months
Fasting glucose, hemoglobin A1c, glucose 2 hours post-oral glucose tolerance test, HOMA-IR index
Time frame: 6 and 12 months
Fasting lipid profile
Time frame: 6 and 12 months
Apolipoprotein B
Time frame: 6 and 12 months
Highly-sensitive C-reactive protein
Time frame: 6 and 12 months
Exercise behavior questionnaire scores
Time frame: 6 and 12 months
Any adverse events
Time frame: 6 and 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.